IFNλ1 is reported elevated in Long COVID-19 subjects versus healthy controls at 4 and 8 months post mild-moderate SARS-CoV-2 infection (Phetsouphanh et al., 2022). The gene discussed is IFNL1; the disease is COVID-19.